Financials data is unavailable for this security.
View more
Year on year Tissue Regenix Group PLC grew revenues 20.50% from 24.48m to 29.49m. Additionally the company has reduced the cost of goods sold, selling, general and administrative expenses and debt expenses (all as percentages of sales). These changes narrowed profitability losses from -2.70m to -1.71m.
Gross margin | 47.60% |
---|---|
Net profit margin | -5.62% |
Operating margin | -1.34% |
Return on assets | -3.71% |
---|---|
Return on equity | -5.58% |
Return on investment | -4.17% |
More ▼
Cash flow in USDView more
In 2022, cash reserves at Tissue Regenix Group PLC fell by 1.76m. Cash Flow from Financing totalled 910.00k or 3.72% of revenues. In addition the company used 1.29m for operations while cash used for investing totalled 1.08m.
Cash flow per share | -0.0077 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.3406 |
---|---|
Tangible book value per share | 0.1696 |
More ▼